Interval Partners LP Has $7.58 Million Stock Position in MetLife, Inc. (NYSE:MET)

Interval Partners LP lessened its holdings in shares of MetLife, Inc. (NYSE:MET) by 71.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 108,035 shares of the financial services provider’s stock after selling 266,744 shares during the quarter. Interval Partners LP’s holdings in MetLife were worth $7,583,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of MET. Public Sector Pension Investment Board raised its stake in MetLife by 347.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 432,887 shares of the financial services provider’s stock valued at $30,384,000 after acquiring an additional 336,127 shares during the period. DRW Securities LLC acquired a new position in shares of MetLife in the second quarter valued at $789,000. EverSource Wealth Advisors LLC raised its position in shares of MetLife by 68.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,826 shares of the financial services provider’s stock valued at $217,000 after purchasing an additional 1,151 shares during the period. 1832 Asset Management L.P. lifted its stake in shares of MetLife by 79.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,344 shares of the financial services provider’s stock worth $94,000 after buying an additional 593 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC boosted its holdings in shares of MetLife by 28.0% during the 2nd quarter. Mount Yale Investment Advisors LLC now owns 15,022 shares of the financial services provider’s stock worth $1,054,000 after buying an additional 3,284 shares during the period. Institutional investors own 89.81% of the company’s stock.

MetLife Stock Performance

NYSE MET opened at $80.85 on Monday. MetLife, Inc. has a 1 year low of $57.91 and a 1 year high of $81.39. The firm has a market capitalization of $57.49 billion, a price-to-earnings ratio of 27.78, a P/E/G ratio of 0.61 and a beta of 1.04. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.56. The firm’s 50 day simple moving average is $74.66 and its 200 day simple moving average is $72.64.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.15. The company had revenue of $17.82 billion for the quarter, compared to analyst estimates of $18.57 billion. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter last year, the company posted $1.94 EPS. As a group, research analysts expect that MetLife, Inc. will post 8.67 earnings per share for the current fiscal year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 10th. Investors of record on Tuesday, August 6th were given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.70%. The ex-dividend date of this dividend was Tuesday, August 6th. MetLife’s dividend payout ratio is 74.91%.

Analysts Set New Price Targets

MET has been the subject of several research reports. JPMorgan Chase & Co. raised their price objective on shares of MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 2nd. Jefferies Financial Group lifted their price target on MetLife from $83.00 to $86.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. Barclays began coverage on MetLife in a research report on Wednesday, September 4th. They set an “overweight” rating and a $91.00 price objective on the stock. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research report on Tuesday, September 10th. Finally, Citigroup raised their price target on shares of MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $84.54.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.